Abivax (ABVX) Cash from Investing Activities (2024 - 2026)

Abivax's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at $579519.1 for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 49.08% year-over-year to $579519.1; the TTM figure through Mar 2026 stood at -$10.2 million (down 163.3% YoY), while the FY2025 annual figure was -$9.5 million, down 156.53% from the prior year.
• Cash from Investing Activities was $579519.1 for Q1 2026 at Abivax, up from -$14.8 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $12.4 million in Q2 2024 to a low of -$14.8 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged $887626.8 across 3 years, with a median of $1.1 million in 2025.
• Biggest YoY gain for Cash from Investing Activities was 99.75% in 2025; the steepest drop was 2438.01% in 2025.
• A 3-year view of Cash from Investing Activities shows it stood at $634745.7 in 2024, then slumped by 2438.01% to -$14.8 million in 2025, then surged by 103.91% to $579519.1 in 2026.
• The last three Cash from Investing Activities figures came in at $579519.1 (Q1 2026), -$14.8 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.